|
FUCA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.103800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.624200E-01 |
| Normal-vs-Stage2 |
9.707800E-02 |
| Normal-vs-Stage3 |
4.098600E-01 |
| Normal-vs-Stage4 |
4.948600E-01 |
| Stage1-vs-Stage2 |
6.335900E-02 |
| Stage1-vs-Stage3 |
1.596430E-01 |
| Stage1-vs-Stage4 |
2.818000E-01 |
| Stage2-vs-Stage3 |
2.014300E-02 |
| Stage2-vs-Stage4 |
4.771800E-02 |
| Stage3-vs-Stage4 |
9.613600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.326000E-01 |
| Normal-vs-AfricanAmerican |
7.786800E-01 |
| Normal-vs-Asian |
5.773200E-01 |
| Caucasian-vs-AfricanAmerican |
5.309400E-01 |
| Caucasian-vs-Asian |
2.835200E-01 |
| AfricanAmerican-vs-Asian |
8.749000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.835600E-01 |
| Normal-vs-Female |
9.758800E-01 |
| Male-vs-Female |
7.424000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.774600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.098600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.102200E-01 |
| Normal-vs-Age(81-100Yrs) |
3.652200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.764400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.210000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.220600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.420200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.508000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.673400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.106200E-02 |
| Classical-VS-Follicular |
4.398000E-02 |
| Classical-VS-Other |
2.762000E-01 |
| Classical-VS-Normal |
9.190000E-01 |
| Tall-VS-Follicular |
5.212100E-04 |
| Tall-VS-Other |
8.344000E-01 |
| Tall-VS-Normal |
3.911500E-02 |
| Follicular-VS-Other |
2.003900E-02 |
| Follicular-VS-Normal |
1.015200E-01 |
| Other-VS-Normal |
1.772000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.833400E-01 |
| Normal-vs-N1 |
1.355200E-01 |
| N0-vs-N1 |
9.224300E-02 |
|
|
